Putnam Investments, the fourth-largest US mutual fund company, said it may close some of its 66 funds as sales and returns lag.
"Putnam is in the final stages of a comprehensive product lineup review," spokesman Matt Keenan said. "The company is considering making changes, possibly including closing or merging some funds." Putnam's stock funds went from leaders in the bull market that ended in March 2000, to laggards in the bear market because some had large holdings of technology stocks, said Kelli Stebel, analyst at fund tracker Morningstar Inc.
"They really bet the farm on tech," Stebel said. "You wouldn't think that a firm that large, with that many resources, would make such a large sector bet."
Lawrence Lasser, Putnam's chief executive, last June said company's growth stock managers were "too aggressive" during the bull market and that changes were in the offing. He said a review was underway, focused on the process managers followed and how their decisions were monitored.
As performance and sales have suffered industrywide, the number of funds liquidated or merged into other funds nearly tripled to 523 last year from 187 in 1999, according to Morningstar. Fund mergers generally require shareholder approval.
An announcement of any decision by the funds' board of trustees will be made "soon," Keenan said. The board was holding its monthly meeting today, he said. Boston-based Putnam, with US$315 billion under management at the end of last year, is a unit of Marsh & McLennan Cos, the biggest insurance broker.
The possibility that Putnam will soon merge some funds was reported earlier by the Web site Ignites.com.
At the end of 1999, the average Putnam stock fund had a three- year record in the top 37 percent of its peers, according to fund tracker Lipper. By the end of last year, the average Putnam stock fund's three-year record was in the top 53 percent.
Putnam's largest stock funds deteriorated more than average.
Its 10 largest stock funds, on average, were in the top third of their peers at the end of 1999, based on their performance over the previous three years. By the end of 2001, the funds were in the bottom 38 percent on average.
The US$16 billion Putnam New Opportunities Fund, in the top 32 percent of its peers at the end of 1999, was in the bottom 32 percent by the end of 2001. The US$3.13 billion Putnam OTC & Emerging Growth Fund, in the top 19 percent of its peers at the end of 1999, was in the bottom 2 percent at the end of 2001.
In January, Putnam fired Steve Kirson, a manager of OTC & Emerging Growth since 1996.
Stocks accounted for 79 percent of Putnam's assets under management at the end of last year.
As the funds slid, sales nose-dived. Putnam went from being the third-best selling of the 25 largest mutual fund groups in 2000 to the fourth-worst in 2001, according to Financial Research Corp, a Boston-based consulting firm. Investors pulled US$4.51 billion from Putnam's funds in 2001 after having added US$16.5 billion in 2000, according to FRC.
The poor performance of some Putnam funds during the bear market "came as a jolt, and had an impact on the confidence level that intermediaries had in Putnam," said Burton Greenwald, a Philidelphia-based mutual fund consultant, referring to the brokers who sell Putnam's funds.
Putnam is likeliest to close its most poorly performing funds, Greenwald said. "It's not likely those funds, given their recent records, are going to attract many new assets," he said.
"It would seem to be in their best interest, and possibly in shareholders' best interest, to collapse those funds into larger funds."
At the end of 2001, nine of Putnam's 28 stock funds rated by Morningstar were rated four or five, the two highest ratings, down from 14 at the end of 1999. Funds rated four or five by Morningstar capture a disproportionate share of the new money invested in funds, according to analysts.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained